Rob Gnepper

Rob Gnepper is an experienced professional in the pharmaceutical sales industry, currently serving as an Ophthalmic Account Manager at SUN PHARMA since May 2023. Previously, Rob held the position of Sr Territory Sales Manager at Urovant Sciences, Inc., where responsibilities included launching a new Beta 3 agonist for the treatment of overactive bladder in Northwest Ohio. With a background in rare disease management at Intercept Pharmaceuticals and clinical oncology at The University of Toledo College of Medicine and Life Sciences, Rob has a proven track record in developing new trials and marketing strategies. Prior experience includes roles at Gilead Sciences and Daiichi Sankyo, focusing on cardiovascular therapeutics. Rob earned a Bachelor's degree from The Ohio State University and completed education at Ottawa Hills High School.